Search Results 321-330 of 17155 for monoclonal antibody
Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the patient's immune system attack the cancer, and may interfere with the ability ...
The model can accurately predict whether a patient will respond to calcitonin gene-related peptide monoclonal antibody medications, also called CGRP mAbs.
This medicine is a monoclonal antibody that works on the immune system. This medicine is to be given only by or under the direct supervision of your doctor ...
Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...
Risankizumab also is a monoclonal antibody. This medicine acts against a molecule known as interleukin-23. Risankizumab was recently approved for treating ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Trastuzumab-dttb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...
diff infections. Bezlotoxumab is a human monoclonal antibody, a medicine that supports the immune system. When there is a risk of a repeat infection, this may ...
Monoclonal antibodies, such as isatuximab, may ... Patients must not have any known allergies to isatuximab or other monoclonal antibody therapies.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.